<DOC>
	<DOCNO>NCT00215176</DOCNO>
	<brief_summary>The purpose study : 1 ) evaluate short-term efficacy safety modafinil atypical depression ; 2 ) evaluate efficacy modafinil prevent relapse atypical depression . The hypothesis modafinil safe effective treatment atypical depression .</brief_summary>
	<brief_title>Modafinil Atypical Depression</brief_title>
	<detailed_description>This study safety efficacy modafinil atypical depression initial 12-week open label treatment period modafinil follow 12-week double-blind , randomize parallel treatment period either modafinil matching placebo . Patients demonstrate least minimal improvement 12 week randomly assign either continue treatment current dose switch match placebo 12 week .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>adult 1865 year age DSMIV criterion major depressive episode atypical feature assess Atypical Depression Diagnostic Scale minimum score 18 Hamilton Depression Scale ( 29item version ) baseline baseline Clinical Global Impressions Severity score 4 write informed consent negative serum pregnancy test woman childbearing potential current primary DSMIV Axis I disorder depression history DSMIV diagnosis bipolar I disorder , schizophrenia psychotic disorder , mental retardation pervasive developmental disorder , cognitive disorder due general medical condition history substance abuse dependence within last 3 month suicide risk serious suicide attempt last year clinically significant medical condition laboratory EKG abnormality history nonresponse three prior adequate trial antidepressant woman childbearing potential unwilling practice acceptable method contraception history hypersensitivity modafinil use investigational medication within last 28 day use antidepressant medication 28 day screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>atypical depression</keyword>
	<keyword>psychostimulants</keyword>
	<keyword>modafinil</keyword>
</DOC>